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Introduction
According to modern ideas, free radical reactions attribute 
to fundamental processes, ensuring normal functioning of 
an organism and are involved in the development of most 
forms of pathology. Numerous experimental and clinical 
observations proved the participation of reactive oxygen spe-
cies (ROS) and initiated their lipid peroxidation (LPO) in the 
pathogenesis of many diseases, including diabetes mellitus 
[1, 2]. The most important link of pathogenesis of diabetes 
mellitus (DM) is a destabilization of membrane structures, 
characterized by quantitative and qualitative changes in the 
lipid bilayer plasma membrane of cells. Various etiological 
factors, such as inflammation, tissue ischemia leads to changes 
in the activity of membrane enzymes, which can lead to shifts 
in the lipid structure of cell membranes and activation of lipid 
peroxidation, which in turn forms a symptom of renal impair-
ment, intoxication, and immune deficiency [3]. Disruption of 
the normal functioning of the immune system contributes to 
the generalization of inflammatory processes, development of 
complications, lack or loss of clinical effect of basic therapy, 
and an increase in mortality.
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Abstract
Experimental and clinical observations proved the participation of reactive oxygen species (ROS) and initiated their lipid peroxidation (LPO) in 
the pathogenesis of many diseases, including diabetes mellitus. The studies were conducted with the blood of 57 patients with type 2 diabetes (male 
21, female 36). All patients were divided into 3 groups based on the duration of the disease, as well as glucose levels: 1 year – compensation stage (n = 
27); from 6 to 10 years – the stage subcompensation (n = 12); and more than 10 years – the stage of decompensation (n = 18). The amount of glucose 
was determined by the glucose oxidase method using ready commercial reagent. As a biochemical marker also was determined level of HBA1c. As a 
result conducted experiments was determined,that in all 3 stage of desease there is an increased level of LPO, also consentration of MDA, DC. LPO 
processes were quantitatively investigated using the spectrophotometric method, we determined serum levels of conjugated dynes – primary products 
of lipid peroxidation and malondialdehyde (MDA) – one of the secondary products. Ferritin levels were determined using a commercial reagent for 
immunosorbent assay of human ferritin. There is noticeable changes in dates of AOS-decreases the level of reduced glutation,catalase,in contrary increases 
the level of ceruloplamin. In maximum grade there is incease in level of ferritin – 2.4 times. These dates prove that depending level of glucose in blood 
increase LPO and decreases AOS of organism.
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Перекисное окисление липидов и показатели антиоксидантной системы при сахарном диабете типа 2
Экспериментальные и клинические наблюдения доказали участие активных форм кислорода и инициируемых ими перекисного окисления 
липидов в патогенезе многих болезней, в том числе сахарного диабета. Исследования были проведены с кровью 57 пациентов (21 мужчин и 36 
женщин) с сахарным диабетом типа 2. Все больные, в зависимости от уровня гликемии и продолжительности заболевания, были разделены на 
3 группы: до 1 года – стадия компенсации, (21 чел.), от 6-10 лет – стадия субкомпенсации (12 чел.) и более чем 10 лет – стадия декомпенсации 
(18 чел.). Количество глюкозы было определено глюкозоксидантным методом с использованием готового коммерческого набора реагента. В 
качестве биохимического маркера также был определен уровень гликозилированного гемоглобина (НbA1c). Процессы перекисного окисления 
липидов (ПОЛ) были количественно исследованы с применением спектрофотометрических методов, были определены уровень диеновых 
конъюгатов – первичных продуктов перекисного окисления и малонового диальдегида (МДА) – одного из вторичных продуктов ПОЛ в 
плазме крови. Уровень ферритина был установлен с использованием коммерческого набора для иммуноферментного анализа. В результате 
проведенных исследований выявлено, что на всех 3-х стадиях заболевания происходит нарастание уровня ПОЛ, возрастает концентрация 
МДА и ДК. Заметное изменение происходит по показателям АОС – снижается уровень восстановленного глутатиона, каталазы и наоборот, 
увеличивается уровень церулоплазмина. В наибольшей степени увеличивается уровень ферритина в 2,4 раза. Эти данные доказывают, что в 
зависимости от уровня глюкозы в крови усиливается ПОЛ и снижается АОС организма.
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In the pathogenesis of diabetes, imbalance between lipid 
peroxidation and antioxidant system (AOS) plays a significant 
role. Reasons for the increase of LPO in the organs and tissues 
can be attributed to either increased generation of reactive 
oxygen metabolites by neutrophils or the lack of effective-
ness of antioxidants [4]. Diabetes mellitus remains one of 
the predominate conditions of clinical medicine and public 
health in connection with an increasing number of patients 
in all countries, including Azerbaijan. According to WHO, 
there are more than 175 million patients with diabetes. Expert 
assessment of the prevalence of the disease suggests that by 
2030 there will be more than 230 million patients diagnosed 
with diabetes, and by 2025300 million diabetic patients will 
be diagnosed, of whom 80-90% will be patients with diabetes 
mellitus type 2 [5, 10].
The purpose of this study was to investigate the state of 
lipid peroxidation and antioxidant system in blood plasma of 
patients with type 2 diabetes mellitus.
Material and methods
The studies were conducted with the blood of 57 patients 
with type 2 diabetes (male 21, female 36). The bulk of patients 
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were treated in the self-supporting Endocrinology Dispen-
sary, Baku. All patients were divided into 3 groups based on 
the duration of the disease, as well as glucose levels: 1 year 
– compensation stage (n = 27); from 6 to 10 years – the stage 
subcompensation (n = 12); and more than 10 years – the stage 
of decompensation (n = 18). The amount of glucose was de-
termined by the glucose oxidase method, ready to jet-set [2]. 
Concentration of HbA1 was determined by special metods 
[3]. The duration of disease was determined by the amount 
of glucose and HbA1 [6]. LPO processes were quantitatively 
investigated by spectrophotometric method; we determined 
serum levels of conjugated dienes – primary products of lipid 
peroxidation and malondialdehyde (MDA) – one of the se- 
condary products. The principle method for the determi-
nation of malondialdehyde was based on the formation of 
colored trimetin complex with thiobarbituric acid at high 
temperatures [7]. The optical density of the colored complex 
after its extraction with n-butanol was carried out at a length of 
532 nm in comparison with control samples. Molar extinction 
of MDA 1.56 M-1 cm-1. The concentration of malondialde-
hyde was expressed in nmol/ml serum. The state of AOS was 
determined by the level in the serum of patients with super-
oxide dismutase (SOD) and GP [9]. In addition, the measured 
integral parameters balance of LPO and AOS, which is used to 
calculate the mathematical equation where one side contains 
the product of the relative values of lipid peroxidation, and 
the other indicators of AOS. The level of copper-containing 
enzyme ceruloplasmin (Cp) was determined by Revin [8]. 
Ferritin levels were determined using a commercial reagent 
for immunosorbent assay of human ferritin.
Results and discussion
The resulting biochemical data from the conducted experi-
ments are presented in table 1.
With prolonged and persistent violation of carbohydrate 
metabolism, decompensation of diabetes mellitus and the 
lack of adequate correction of the disease increased the 
levels of HbA1. In parallel, non-enzymatic glycosylation of 
hemoglobin and other proteins is an organism that can cause 
such changes characteristic of the progression of diabetes as a 
thickening of the membrane, metabolic disorders. Indicators 
of LPO and AOS are shown in table 2.
DM patients exhibited regular increases in the content 
of MDA and DC in the blood serum with maximal values in 
patients with diabetes at the stage of decompensation. These 
changes have taken place against the background of the main 
biochemical parameters – increase in the level of glucose in 
the blood serum. The level of reduced glutathione (GSH), 
on the contrary, decreases depending on the severity of the 
disease. Thus, the MDA level in diabetic patients in group I 
increased by 1.6 times, in the group II 2.4 times and in group 
III 3.1 times. Almost the same dynamics of change were ob-
served for diene conjugates (DC). In patients with conserva-
tive groups an increase of 1.8 times was observed; whereas 
in the terminal group an increase of 2.4 times was observed.
The level of CP (ceruloplasmin) in the blood plasma of 
patients with CD was reduced in comparison with indicators 
of healthy patients, after applying the appropriate treatment, a 
noticeable improvement was observed. Apparently, this is due 
to a well-compensated response of the body upon the activa-
tion of LPO processes at this stage of the disease. In stage III 
of the disease there was a significant reduction level of CP.
In this study, the determination of the activity of glutathi-
Table 2
LPO and AOS in patients with type 2 diabetes  compared with the control
Dates Control In the state сompensation Subcompensation Decompensation
MDA, nmol/l 3.7 ± 0.1 6.01 ± 1.22* 8.69 ± 1.87* 12.48 ± 1.54*
DK, Е223/ml 0.46 ± 0.02 0.48 ± 0.02* 0.82 ± 0.02*   1.1 ± 0.02*
GSH mkmol/l 1.89 ± 0.04 1.53 ± 0.18* 1.44 ± 0.21* 1.29 ± 0.19
SOD, IU/mq  806 ± 23.14 986 ± 193* 998 ± 122* 1195 ± 166*
CАТ 72.98 ± 2.32 51.64 ± 9.81* 49.16 ± 8.41*  60.91 ± 13.20*
GPO, U/qHb  46.8 ± 1.04 59.23 ± 11.2* 62.69 ± 8.63* 65.78 ± 9.30*
Ceruloplazmin, mkq% 17.85 ± 0.61 35.57 ± 9.50* 32.25 ± 10.43* 31.54 ± 9.57*
Ferritin, nq/ml 139.93 ± 3.58 314.98 ± 97.54* 234.27 ± 87.38* 329.72 ± 82.87*
*p < 0,05
Table 1
Blood glucose levels and glycated hemoglobin in patients 
with type 2 diabetes
Group of diabetic 
patients
Number 
of pa-
tients
Average daily 
blood glucose,
mmol/l
HbA1C%
In the state 
сompensation
27 5.74 ± 0.14 6.5 ± 0.55
Subcompensation 12 8.1 ± 0.18 * 7.7 ± 3.31
Decompensation 18 8.74 ± 0.58 10.5 ± 0.82**
Control 20 3.8 ± 0.22 5.4 ± 0.91
*p < 0,05,**p < 0,005
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one peroxidase in the blood serum of patients with diabetes 
was carried out using hydrogen peroxide and 5.5′-dithiobis 
(2-nitrobenzoic acid [5]. Selenium glutathione peroxidases 
(GPO) are a group of enzymes catalyzing the recovery of 
hydrogen peroxide (H
2
O
2
) and organic peroxides, used as an 
electron donor for the reduced form of glutathione (GSH). 
Selenocysteine is present in the enzymes of this group, which 
makes them sensitive to the content of selenium in tissues. It 
is known that selenium is an essential element for the biosyn-
thesis of selendepended GPO. A deficiency of selenium causes 
a decrease in the level determined by the glutationperoxidase 
activity in many organs and tissues. Selenium of GPO inter-
acts effectively with a wide range of compounds containing 
peroxide groups. To determine the activity of these enzymes, 
often several organic peroxides are used. At the same time, 
selenium GPO is not the only group of enzymes that can re-
store the peroxides formed in vivo. The recovery of peroxide 
groups of biomolecules and other functional groups related to 
SH groups of glutathione (GSH) and peroxiredoxins, which 
in the aggregate may be designated as non-selencontaining 
enzymes. In some tissues, the glutathione peroxidase activity 
is comparable to or even exceeds the activity of enzymes with 
selenium forming the same reactions.
Ferritin is the major protein of the human body stocking 
with a molecular weight 450000. It is characterized by a 
strong tertiary structure close to spherical, aimed at preserving 
large amounts of iron in a soluble, easily metabolized form. 
All ferritin interact with iron (II) in the reaction catalyzed in 
a ferroxidase center, inducing its oxidation and deposition in 
the cavity in a mineral form. Thus, depending on the glycemia 
level in patients with type 2 diabetes, observations were made 
of increased LPO processes and reducing components AOC 
system, which determines the complications of diabetes.
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Aspectul terapeutic al Ronocitului (CDP-cholina)  
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Therapeutic view of Ronocit (CDP-choline) in children with migraine headaches
We performed a study of the frequency and duration of migraine headaches and specific changes in EEG and dynamics of laboratory changes in 
serum of cardiolipin, phospholtidilcolin, sphyngomyelin and α-fetoprotein with the immunoferment screening analysis method (ELISA) before and 
after treatment.  Ronocit was administrated parenterally and orally for a period of 40 days at a dose of 1000 mg in two divided doses. While reducing 
the frequency and duration of headaches in children, an increased lipid metabolism was observed, especially of phospholipids. A parenteral treatment 
period of 10 days in patients with migraine headaches were compared with the results from the treatment of children with Cerebral Palsy.  By analyzing 
side effects, of Ronocit in children with migraine headaches and cerebral palsy, we can conclude that no side effects were noted. There was a clinical and 
neurophysiological (EEG) improvement in the frequency and duration of migraine access, while increasing antioxidant defense system. This aspect can 
be used for prophylactic migraine access in children.
Key words: Ronocit, migraine, headache, access, immunoferment screening.
